Platelets arachidonic acid metabolism in patients with essential hypertension

Platelets

Volumn 20, Issue 4, 2009, Pages 242-249

  Dogowska, Barbara ^a   Bogowski, Wojciech ^a   Kdzierska, Karolina ^a   Safranow, Krzysztof ^a   Jakubowska, Katarzyna ^a   Olszewska, Maria ^a   Rac, Monika ^a   Chlubek, Dariusz ^a   Ciechanowski, Kazimierz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Essential hypertension; HETE acids; Isoprostanes; Platelets; Thromboxane

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; THROMBOXANE B2;

ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; HUMAN; MALE; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINE;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ADULT; ARACHIDONIC ACID; ATHEROSCLEROSIS; BLOOD PLATELETS; CASE-CONTROL STUDIES; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; MALE; MIDDLE AGED; THROMBOXANE B2;

EID: 67651146525     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100902849836     Document Type: Article

References (36)

1. Nasjletti A. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension 1998;31:194-200.
2. 2 in postischemic "no-reflow" and "reflow- paradox". J Surg Res 2004;120:1-11.
3. Foidart JB, McNish RW, Coffey MJ, Ojo TC, Phare SM, Peters-Golden M. Effect of granulocyte - macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes. J Immunol 1996;156:2522-2527.
4. Natarajan R, Rosdahl J, Gonzales N, Bai W. Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells. Hypertension 1997;30:873-879.
5. Gonzalez-Nunez D, Claria J, Rivera F, Poch E. Increased levels of 12(S)-HETE in patients with essential hypertension. Hypertension 2001;37:334-338.
6. Dolegowska B, Chlubek D. Lipoxygenase superfamily - structure and function in metabolism. Postepy Biochem 2002;48: 275-286.
7. 1) does not improve renal function in hepatic transplant recipiens. J Am Coll Surg 1996;182:347-352.
8. Stanke-Labesque F, Hardy G, Cracowski JL, Bessard G. Leukotrienes and 12-HETE: Key mediators of angiotensis II-mediated vascular effects. Role in hypertension. Therapie 2002;57:151-156.
9. Stern N, Nozawa K, Kisch E, Tuck ML, Golub M, Eggena P, Knoll E. Tonic inhibition of renin secretion by the 12-lipoxygenase pathway augmentation by high salt intake. Endocrinology 1996;137:18778-18784.
10. Yiu SS, Zhao X, Inscho EW, Imig JD. 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels. J. Lipid Res 2003;44:2391-2399.
11. 2α increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vase Biol 1998;18:1248-1256.
12. Dolegowska B, Chlubek D. Isoprostanes-new possibility of the oxidative stress estimation. Przegl Lek 2004;61: 1410-1414.
13. Rokach J, Khanapure SP, Hwang SW, Adiyaman M, Lawson JA, FitzGerald GA. Nomenclature of isoprostanes: A proposal. Prostaglandins 1997;54:853-873.
14. Leitinger N, Blazek I, Sinzinger H. The influenze of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets. Thromb Res 1997;86: 337-342.
15. 2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J Biol Chem 2006;281: 4616-4623.
16. 2 receptors. J Clin Invest 1992;90: 136-141.
17. Fukunaga M, Makita M, Roberts LJ, Morrow JD, Takahashi K, Badr KF. Evidence for the existance of the F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993;264:1619-1624.
18. Reid TJ, Esteban G, Clear M, Gorogias M. Platelet membrane integrity during storage and activation. Transfusion 1999;39:616-624.
19. Rothwell SW, Maglasang P, Reid TJ, Gorogias M, Krishnamurti C. Correlation of in vivo and in vitro functions of fresh and stored human platelets. Transfusion 2000;40: 988-993.
20. Dolegowska B, Pikula E, Safranow K, Olsezewska M, Jakubowska K, Chlubek D, Gutowski P. Metabolism of eicosanoids and their action on renal function during ischaemia and reperfusion: The effect of alprostadil. Prostaglandins Leukot Essent Fatty Acids 2006;75:403-411.
21. Dolegowska B, Blogowski W, Domanski L. Is it possible to predict the early post-transplant allograft function using 20-HETE measurements? A preliminary report. Transpl Int 2009a;22:546-553.
22. Dolegowska B, Blogowski W, Domanski L. Dynamics of thromboxane levels' changes during early phase of allograft reperfusion. Clin Transplant 2009b (in press).
23. Dolegowska B, Blogowski W, Safranow K, Jakubowska K, Olsewska M, Domanski L. Selected aspects of lipoxygenase pathway of arachidonic acid metabolism during ischemia-reperfusion injury and their influence on 20-HETE synthesis. Transpl Int 2009c (in press).
24. Wen Y, Gu J, Chakrabarti SK, Aylor K, Marshall J, Takahashi Y, Yoshimoto T, Nadler JL. The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages. Endocrinology 2007;148: 1313-1322.
25. Wen Y, Gu J, Vandenhoff GE, Liu X, Nadler JL. Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. Am J Physiol Heart Circ Physiol 2008;294: H1933-H1938.
26. Delias C, Schafer K, Rohm IK, Lankeit M, Leifheit M, Loskutoff DJ, Hasenfuss G, Konstantinides SV. Leptin signaling and leptin-mediated activation of human platelets: Importance of JAK2 and the phospholi-pases Cgamma2 and A2. Thromb Haemost 2007;98: 1063-1071.
27. Sugiyama C, Ishizawa M, Kajita K, Morita H, Uno Y, Matsubara K, Matsumoto M, Ikeda T, Ishizuka T. Platelet aggregation in obese and diabetic subjects: Association with leptin level. Platelets 2007;18:128-134.
28. Blogowska A, Rzepka-Gorska I, Krzyzanowska-Swiniarska K, Zoltowski S, Kosmowska B. Leptin, neuropeptide Y, beta-endorphin, gonadotropin and estradiol levels in girls before menarche. Gynecol Endocrinol 2003;17:7-12.
29. Cirillo D, Rachiglio AM, la Montagna R, Giordano A, Normanno N. Leptin signaling in breast cancer: An overview. J Cell Biochem 2008;105:956-964.
30. Blogowska A, Rzepka-Gorska I, Krzyzanowska-Swiniarska K. Body composition, dehydroepiandrosterone sulfate and leptin concentrations in girls approaching menarche. J Pediatr Endocrinol Metab 2005;18:975-983.
31. Imatoh T, Miyazaki M, Momose Y, Uryu Y, Tanihara S, Une H, Doi H. Hyperleptinemia is associated with hypertension in Japanese males. Acta Med Okayama 2008;62:169-174.
32. Blogowska A, Krzyzanowska-Swiniarska B, Zielinska D, Rzepka-Gorska I. Body composition and concentrations of leptin, neuropeptide Y, beta-endorphin, growth hormone, insulin-like growth factor-I, and insulin at menarche in girls with constitutional delay of puberty. Gynecol Endocrinol 2006;22:274-278.
33. Trolliet MR, Rudd MA, Loscalzo J. Oxidative stress and renal dysfunction in salt-sensitive hypertension. Kidney Blood Press Res 2001;24:116-123.
34. 2α in vitro and in vivo via the cyclooxygenases. Pharm Exp Therap 1997; 282:1658-1665.
35. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, Seta F, Capone ML, Tacconelli S, Paletresi S. et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 2002;106:2800-2805.
36. 2α in normal and hypercholesterolemic pigs. Am J Physiol Regul Integr Comp Physiol 2002;283:R303-R308.